Pharmaceutical producers, importers undergo training
A training programme on how to finalise the registration of products before they are supplied to the market opened for importers and local manufacturers of pharmaceutical products in Accra yesterday.
Advertisement
The three-day course, organised by the Food and Drugs Authority (FDA), is funded by the Department for International Development (DFID) of the UK, as part of efforts to ensure that pharmaceutical products on the Ghanaian market are of good quality.
The Deputy Chief Executive Officer of the FDA, Mr Odame Darkwa, speaking at the opening session, explained that the training programme had been designed to correct deficiencies that had been identified in the processing of medicine registration applications.
He said the course would also provide vital information required for the registration of the pharmaceutical products and thus, reduce the delays associated with the process.
Challenges
Mr Darkwa expressed concern about applicants refusing to provide the required additional information in support of their registration application.
He said the information was needed to clarify issues related to the quality and safety of the products before they were distributed to the market.
Objectives
The Senior Regulatory Officer at the Drug Registration Regulatory Department (DRRD) of the FDA, Mr Eric Owusu, said the main objective of the course was to ensure that all products were of good quality and safe for use.
The FDA, he said, continued to organise periodic training for the local pharmaceutical manufacturing industry to enable them to compete fairly with their foreign counterparts and expressed the hope that the workshop would make drug registration easier and faster.
